BioCentury
ARTICLE | Company News

Glycomed Inc. deal

January 23, 1995 8:00 AM UTC

The Alameda, Calif., company extended for two years its 1992 agreement with the Alberta Research Council (ARC) to develop carbohydrate-based therapeutics to treat inflammatory diseases. ARC is contrib...